½ÃÀ庸°í¼­
»óǰÄÚµå
1786835

´õ¸» ÇÊ·¯ ½ÃÀå : ½ÃÀå ±Ô¸ð, Á¡À¯À², »ê¾÷ ºÐ¼® º¸°í¼­ - Á¦Ç°º°, ¾àÁ¦ À¯Çüº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº° ½ÃÀå ¿¹Ãø(2025-2034³â)

Dermal Fillers Market Size, Share, & Industry Analysis Report By Product (Hyaluronic Acid, Calcium Hydroxyl Apatite), By Drug Type, By Application, By End User, and By Region - Market Forecast, 2025-2034

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Polaris Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 129 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Polaris Market ResearchÀÇ ÃÖ±Ù Á¶»ç¿¡ µû¸£¸é, ´õ¸» ÇÊ·¯ ½ÃÀå ±Ô¸ð´Â 2034³â±îÁö 140¾ï 7,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¼³¹®Á¶»ç º¸°í¼­´Â ÇöÀç ½ÃÀå ¿ªÇÐÀ» ÀÚ¼¼È÷ ÆÄ¾ÇÇϰí ÇâÈÄ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

¼¼°èÀÇ ´õ¸» ÇÊ·¯ ½ÃÀåÀº º¸´Ù ºü¸¥ ȸº¹°ú ´«¿¡ º¸ÀÌ´Â °á°ú¸¦ Á¦°øÇÏ´Â ºñ¿Ü°úÀû ¹Ì¿ë Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó °­·ÂÇÑ ¼ºÀåÀ» ¸ñ°ÝÇϰí ÀÖ½À´Ï´Ù. ´õ¸» ÇÊ·¯´Â ³ëÈ­ÀÇ Â¡Èĸ¦ ¿ÏÈ­Çϰí, ¾ó±¼ÀÇ À±°ûÀ» °³¼±Çϸç, ¾ó±¼ Ç¥Àû ¿µ¿ªÀÇ º¼·ýÀ» º¹±¸ÇÏ´Â µ¥ ³Î¸® »ç¿ëµË´Ï´Ù.

ÀÌ ½ÃÀåÀº ÇÊ·¯ Àç·áÀÇ Áøº¸, ¾ó±¼ ÁÖÀÔ ±â¼ú Çâ»ó, ´Ù¾çÇÑ ¿¬·ÉÃþÀÇ °³ÀÎÀûÀÎ ¿Ü¸ð¿¡ ´ëÇÑ °ü½É Áõ°¡¿¡ ÀÇÇØ ´õ¿í Áö¿øµÇ°í ÀÖ½À´Ï´Ù. Á¦Á¶¾÷ü °¢ ȸ»ç´Â ´õ ¿À·¡ Áö¼ÓµÇ´Â °á°ú¸¦ Á¦°øÇÏ°í ¾ÈÀü¼º ÇÁ·ÎÆÄÀÏÀ» °³¼±ÇÑ Á¦Ç°À» ¹ßÇ¥ÇÕ´Ï´Ù.

´õ¸» ÇÊ·¯ ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

Àç·áº°·Î, È÷¾Ë·ç·Ð»ê ºÎ¹®Àº 2024³â ½ÃÀåÀ» µ¶Á¡Çß½À´Ï´Ù. À̰ÍÀº ½Åü¿¡¼­ ºÐÇØµÇ´Â ÀÚ¿¬ÀûÀÎ ´É·Â ¶§¹®ÀÔ´Ï´Ù.

Á¦Ç°º°·Î »ýºÐÇØ¼º ºÎ¹®Àº 2024³â ½ÃÀåÀ» µ¶Á¡Çß½À´Ï´Ù. ÀÌ´Â ¼¼°èÀûÀ¸·Î ÀÎÁöµÈ Á¦Á¶¾÷üÀÇ Á¸Àç°¨ÀÌ °­Çϰí, °íǰÁúÀÇ ±ÔÁ¦ ´ç±¹ ½ÂÀÎÀ» ¹ÞÀº ´õ¸» ÇÊ·¯ Á¦Ç°À» ÀÌ¿ëÇÒ ¼ö Àֱ⠶§¹®ÀÔ´Ï´Ù.

¾àÁ¦ À¯Çüº°·Î ÀÜÁÖ¸§, ºñ¼ø±¸, À̸¶ÁÖ¸§ µî ÀϹÝÀûÀÎ ³ëÈ­ ¡Èĸ¦ ´ë»óÀ¸·Î ÇÑ Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä°¡ È®»êµÇ°í Àֱ⠶§¹®¿¡ ºê·£µå ºÎ¹®ÀÌ 2024³â ÃÖ´ë ½ÃÀåÁ¡À¯À²À» È®ÀÎÇß½À´Ï´Ù.

¿ëµµº°·Î ÁÖ¸§ ±³Á¤ÀÌ 2024³â¿¡ °¡Àå ³ôÀº CAGRÀ» ±â·ÏÇß½À´Ï´Ù. À̰ÍÀº ÇǺÎÀÇ ¸Å²ô·¯¿ò°ú ź·Â¼ºÀ» ȸº¹½Ã۱â À§ÇØ ÀÜÁÖ¸§ ¹× ¾ó±¼ ÁÖ¸§°ú °°Àº ÀϹÝÀûÀÎ ³ëÈ­ÀÇ Â¡Èĸ¦ ´ë»óÀ¸·Î ÇÊ·¯ ½Ã¼ú¿¡ ´ëÇÑ °­ÇÑ ¼ö¿ä ¶§¹®ÀÔ´Ï´Ù.

ÃÖÁ¾ »ç¿ëÀÚº°·Î ¼÷·ÃµÈ Àü¹®°¡ÀÇ Á¸Àç¿Í ¸ÂÃã Ä¡·á¸¦ Á¦°øÇÔÀ¸·Î½á Àü¹® Ŭ¸®´Ð ¹× ÇǺΰú Ŭ¸®´Ð ºÎ¹®ÀÌ 2024³â ½ÃÀå Á¡À¯À²À» µ¶Á¡Çß½À´Ï´Ù.

ºÏ¹Ì´Â 2024³â ¼¼°èÀÇ ´õ¸» ÇÊ·¯ ½ÃÀå¿¡¼­ ´ëºÎºÐÀÇ Á¡À¯À²À» Â÷ÁöÇߴµ¥, ÀÌ´Â ¹Ì¿ë ½Ã¼ú¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ÁöÃâÀÌ ³ô¾Æ ¹Ì¿ë ÇǺΰúÀÇ »ýŰ谡 È®¸³µÇ¾î Àֱ⠶§¹®ÀÔ´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀº Áß±¹, Çѱ¹, ű¹, Àεµ µî ±¹°¡¿¡¼­ Áß·ù°è±ÞÀÇ Àα¸ Áõ°¡¿Í µµ½ÃÈ­ÀÇ ÁøÀü¿¡ °ßÀÎµÇ¾î ½ÃÀå Á¡À¯À²ÀÌ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù.

¼¼°è ÁÖ¿ä ½ÃÀå ÁøÃâ ±â¾÷Àº AbbVie Inc., Bioplus CO.LTD., Bioxis Pharmaceuticals, Bioha Laboratories, Cutera, Inc., Elan Aesthetics, Inc., Galderma SA, HUADONG MEDICINE CO.KGaA, Prollenium Medical Technologies Inc., Revance Global, Suneva Medical, Inc., Teoxane Laboratories SA µîÀÌ ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¼¼°èÀÇ ´õ¸» ÇÊ·¯ ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ÇöȲ
  • ´õ¸» ÇÊ·¯ ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ ¹× ±âȸ
      • Àúħ½À ¹Ì¿ë ½Ã¼ú ¼ö¿ä Áõ°¡
      • ¼¼°èÀûÀ¸·Î °í·ÉÈ­ ÁøÇà
    • ¼ºÀå ¾ïÁ¦¿äÀÎ ¹× °úÁ¦
      • °í¾×ÀÇ Ä¡·áºñ
  • PESTEL ºÐ¼®
  • ´õ¸» ÇÊ·¯ ½ÃÀå µ¿Çâ
  • ¹ë·ùüÀÎ ºÐ¼®

Á¦5Àå ¼¼°èÀÇ ´õ¸» ÇÊ·¯ ½ÃÀå : Àç·áº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­¹®
  • È÷¾Ë·ç·Ð»ê
  • Ä®½· È÷µå·Ï½Ã¾ÆÆÄŸÀÌÆ®
  • Æú¸®-L-¶ôÆ®»ê
  • PMMA(Æú¸®¸ÞÆ¿¸ÞŸũ¸±·¹ÀÌÆ®)
  • Áö¹æ ÃæÀüÁ¦
  • ±âŸ

Á¦6Àå ¼¼°èÀÇ ´õ¸» ÇÊ·¯ ½ÃÀå : Á¦Ç°º°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­¹®
  • »ýºÐÇØ¼º ¾øÀ½
  • »ýºÐÇØ¼º
  • ÀϽÃÀûÀÎ »ýºÐÇØ¼º
  • ¹Ý¿µ±¸ÀûÀÎ »ýºÐÇØ¼º

Á¦7Àå ¼¼°èÀÇ ´õ¸» ÇÊ·¯ ½ÃÀå : ¾àÁ¦ À¯Çüº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­¹®
  • ºê·£µå
  • Á¦³×¸¯

Á¦8Àå ¼¼°èÀÇ ´õ¸» ÇÊ·¯ ½ÃÀå : ¿ëµµº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­¹®
  • ÁÖ¸§ ±³Á¤
  • ÈäÅÍ Ä¡·á
  • ÀÔ¼ú Áõ°­
  • º¼·ý º¹¿ø
  • ±âŸ

Á¦9Àå ¼¼°èÀÇ ´õ¸» ÇÊ·¯ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­¹®
  • Àü¹® Ŭ¸®´Ð ¹× ÇǺΰú Ŭ¸®´Ð
  • º´¿ø
  • ±âŸ

Á¦10Àå ¼¼°èÀÇ ´õ¸» ÇÊ·¯ ½ÃÀå : Áö¿ªº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­¹®
    • ´õ¸» ÇÊ·¯ ½ÃÀå Æò°¡ : Áö¿ªº°(2020-2034³â)
  • ºÏ¹Ì
    • ºÏ¹Ì : Àç·áº°(2020-2034³â)
    • ºÏ¹Ì : Á¦Ç°º°(2020-2034³â)
    • ºÏ¹Ì : ¾àÁ¦ À¯Çüº°(2020-2034³â)
    • ºÏ¹Ì : ¿ëµµº°(2020-2034³â)
    • ºÏ¹Ì : ÃÖÁ¾ »ç¿ëÀÚº°(2020-2034³â)
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • À¯·´ : Àç·áº°(2020-2034³â)
    • À¯·´ : Á¦Ç°º°(2020-2034³â)
    • À¯·´ : ¾àÁ¦ À¯Çüº°(2020-2034³â)
    • À¯·´ : ¿ëµµº°(2020-2034³â)
    • À¯·´ : ÃÖÁ¾ »ç¿ëÀÚº°(2020-2034³â)
    • ¿µ±¹
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ³×´ú¶õµå
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : Àç·áº°(2020-2034³â)
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : Á¦Ç°º°(2020-2034³â)
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ¾àÁ¦ À¯Çüº°(2020-2034³â)
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ¿ëµµº°(2020-2034³â)
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ÃÖÁ¾ »ç¿ëÀÚº°(2020-2034³â)
    • Áß±¹
    • Àεµ
    • ¸»·¹À̽þÆ
    • ÀϺ»
    • Àεµ³×½Ã¾Æ
    • Çѱ¹
    • È£ÁÖ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : Àç·áº°(2020-2034³â)
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : Á¦Ç°º°(2020-2034³â)
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ¾àÁ¦ À¯Çüº°(2020-2034³â)
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ¿ëµµº°(2020-2034³â)
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ÃÖÁ¾»ç¿ëÀÚº°(2020-2034³â)
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • À̽º¶ó¿¤
    • ³²¾ÆÇÁ¸®Ä«
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ¶óƾ¾Æ¸Þ¸®Ä« : Àç·áº°(2020-2034³â)
    • ¶óƾ¾Æ¸Þ¸®Ä« : Á¦Ç°º°(2020-2034³â)
    • ¶óƾ¾Æ¸Þ¸®Ä« : ¾àÁ¦ À¯Çüº°(2020-2034³â)
    • ¶óƾ¾Æ¸Þ¸®Ä« : ¿ëµµº°(2020-2034³â)
    • ¶óƾ¾Æ¸Þ¸®Ä« : ÃÖÁ¾ »ç¿ëÀÚº°(2020-2034³â)
    • ¸ß½ÃÄÚ
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«

Á¦11Àå °æÀï ±¸µµ

  • È®´ë ¹× Àμö ºÐ¼®
    • È®´ë
    • Àμö
  • Á¦ÈÞ, Çù¾÷, ÇÕÀÇ ¹× °ø°³

Á¦12Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • AbbVie Inc.
  • BIOPLUS CO., LTD.
  • Bioxis Pharmaceuticals
  • Bioha Laboratories
  • Cutera, Inc.
  • Elan Aesthetics, Inc.
  • Galderma SA
  • HUADONG MEDICINE CO., LTD.
  • Merz Pharma GmbH & Co. KGaA
  • Prollenium Medical Technologies Inc.
  • Revance Therapeutics, Inc.
  • Sinclair Pharma Limited
AJY 25.08.18

The dermal fillers market size is expected to reach USD 14.07 Billion by 2034, according to a new study by Polaris Market Research. The report "Dermal Fillers Market Size, Share, Trends, & Industry Analysis Report By Material, By Product (Hyaluronic Acid, Calcium Hydroxyl Apatite), By Drug Type, By Application, By End User, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The global dermal fillers market is witnessing robust growth driven by increasing demand for non-surgical cosmetic procedures that offer faster recovery and visible results. Dermal fillers are widely used to reduce signs of aging, improve facial contours, and restore volume in targeted areas of the face.

The market is further supported by advancements in filler materials, improved facial injectable techniques, and the rising focus on personal appearance across various age groups. Manufacturers are introducing products that provide longer-lasting results and improved safety profiles.

Dermal Fillers Market Report Highlights

Based on material, the hyaluronic acid segment dominated the market in 2024, due to its natural ability to break down within the body.

In terms of product, the biodegradable segment dominated the market in 2024. This is attributed to the strong presence of globally recognized manufacturers, coupled with the availability of high-quality and regulatory-approved dermal filler products.

In terms of drug type, the branded segment witnessed the largest market share in 2024, owing to the widespread demand for treatments targeting common signs of aging such as fine lines, nasolabial folds, and forehead creases.

Based on application, the wrinkle correction is registered highest CAGR in 2024, due to the strong demand for filler procedures that target common aging signs such as fine lines and facial folds to restore skin smoothness and elasticity.

Based on end user, the specialty and dermatology clinics segment dominated the market share in 2024, due to the presence of skilled professionals and personalized treatment offering.

North America accounted for the majority share in the global dermal fillers market in 2024, due to high consumer spending on aesthetic procedures and a well-established cosmetic dermatology ecosystem.

Asia Pacific held fastest growing market share, driven by a growing middle-class population and increased urbanization in countries such as China, South Korea, Thailand, and India.

A few global key market players include AbbVie Inc., BIOPLUS CO., LTD., Bioxis Pharmaceuticals, Bioha Laboratories, Cutera, Inc., Elan Aesthetics, Inc., Galderma S.A., HUADONG MEDICINE CO., LTD., Merz Pharma GmbH & Co. KGaA, Prollenium Medical Technologies Inc., Revance Therapeutics, Inc., Sinclair Pharma Limited, Sosum Global, Suneva Medical, Inc., and Teoxane Laboratories S.A.

Polaris Market Research has segmented the market report on the basis of material, product, drug type, application, end user, and region:

By Material Outlook (Revenue, USD Billion, 2020-2034)

Hyaluronic acid

Calcium hydroxyl apatite

Poly-L-lactic Acid

PMMA (Polymethylmethacrylate)

Fat Fillers

Others

By Product Outlook (Revenue, USD Billion, 2020-2034)

Non-biodegradable

Biodegradable

Temporary biodegradable

Semi-Permanent biodegradable

By Drug Type Outlook (Revenue, USD Billion, 2020-2034)

Branded

Generic

By Application Outlook (Revenue, USD Billion, 2020-2034)

Wrinkle Correction Treatment

Scar treatment

Lip enhancement

Restoration of volume

Others

By End User Outlook (Revenue, USD Billion, 2020-2034)

Specialty and Dermatology Clinics

Hospitals

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Dermal Fillers Market Insights

  • 4.1. Dermal Fillers Market - Market Snapshot
  • 4.2. Dermal Fillers Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Demand for Minimally Invasive Aesthetic Procedures
      • 4.2.1.2. Growing Aging Population Globally
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Treatment Costs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Dermal Fillers Market Trends
  • 4.6. Value Chain Analysis

5. Global Dermal Fillers Market, by Material

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Dermal Fillers Market, by Material, 2020-2034 (USD Billion)
  • 5.3. Hyaluronic acid
    • 5.3.1. Global Dermal Fillers Market, by Hyaluronic acid, by Region, 2020-2034 (USD Billion)
  • 5.4. Calcium hydroxyl apatite
    • 5.4.1. Global Dermal Fillers Market, by Calcium hydroxyl apatite, by Region, 2020-2034 (USD Billion)
  • 5.5. Poly-L-lactic Acid
    • 5.5.1. Global Dermal Fillers Market, by Poly-L-lactic Acid, by Region, 2020-2034 (USD Billion)
  • 5.6. PMMA (Polymethylmethacrylate)
    • 5.6.1. Global Dermal Fillers Market, by PMMA (Polymethylmethacrylate), by Region, 2020-2034 (USD Billion)
  • 5.7. Fat Fillers
    • 5.7.1. Global Dermal Fillers Market, by Fat Fillers, by Region, 2020-2034 (USD Billion)
  • 5.8. Others
    • 5.8.1. Global Dermal Fillers Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Dermal Fillers Market, by Product

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Dermal Fillers Market, by Product, 2020-2034 (USD Billion)
  • 6.3. Non-biodegradable
    • 6.3.1. Global Dermal Fillers Market, by Non-biodegradable, by Region, 2020-2034 (USD Billion)
  • 6.4. Biodegradable
    • 6.4.1. Global Dermal Fillers Market, by Biodegradable, by Region, 2020-2034 (USD Billion)
  • 6.5. Temporary biodegradable
    • 6.5.1. Global Dermal Fillers Market, by Temporary biodegradable, by Region, 2020-2034 (USD Billion)
  • 6.6. Semi-Permanent biodegradable
    • 6.6.1. Global Dermal Fillers Market, by Semi-Permanent biodegradable, by Region, 2020-2034 (USD Billion)

7. Global Dermal Fillers Market, by Drug Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Dermal Fillers Market, by Drug Type, 2020-2034 (USD Billion)
  • 7.3. Branded
    • 7.3.1. Global Dermal Fillers Market, by Branded, by Region, 2020-2034 (USD Billion)
  • 7.4. Generic
    • 7.4.1. Global Dermal Fillers Market, by Generic, by Region, 2020-2034 (USD Billion)

8. Global Dermal Fillers Market, by Application

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Dermal Fillers Market, by Application, 2020-2034 (USD Billion)
  • 8.3. Wrinkle Correction Treatment
    • 8.3.1. Global Dermal Fillers Market, by Wrinkle Correction Treatment, by Region, 2020-2034 (USD Billion)
  • 8.4. Scar treatment
    • 8.4.1. Global Dermal Fillers Market, by Scar treatment, by Region, 2020-2034 (USD Billion)
  • 8.5. Lip enhancement
    • 8.5.1. Global Dermal Fillers Market, by Lip enhancement, by Region, 2020-2034 (USD Billion)
  • 8.6. Restoration of volume
    • 8.6.1. Global Dermal Fillers Market, by Restoration of volume, by Region, 2020-2034 (USD Billion)
  • 8.7. Other
    • 8.7.1. Global Dermal Fillers Market, by Other, by Region, 2020-2034 (USD Billion)

9. Global Dermal Fillers Market, by End User

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Dermal Fillers Market, by End User, 2020-2034 (USD Billion)
  • 9.3. Specialty and Dermatology Clinics
    • 9.3.1. Global Dermal Fillers Market, by Specialty and Dermatology Clinics, by Region, 2020-2034 (USD Billion)
  • 9.4. Hospitals
    • 9.4.1. Global Dermal Fillers Market, by Hospitals, by Region, 2020-2034 (USD Billion)
  • 9.5. Others
    • 9.5.1. Global Dermal Fillers Market, by Others, by Region, 2020-2034 (USD Billion)

10. Global Dermal Fillers Market, by Geography

  • 10.1. Key Findings
  • 10.2. Introduction
    • 10.2.1. Dermal Fillers Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 10.3. Dermal Fillers Market - North America
    • 10.3.1. North America: Dermal Fillers Market, by Material, 2020-2034 (USD Billion)
    • 10.3.2. North America: Dermal Fillers Market, by Product, 2020-2034 (USD Billion)
    • 10.3.3. North America: Dermal Fillers Market, by Drug Type, 2020-2034 (USD Billion)
    • 10.3.4. North America: Dermal Fillers Market, by Application, 2020-2034 (USD Billion)
    • 10.3.5. North America: Dermal Fillers Market, by End User, 2020-2034 (USD Billion)
    • 10.3.6. Dermal Fillers Market - U.S.
      • 10.3.6.1. U.S.: Dermal Fillers Market, by Material, 2020-2034 (USD Billion)
      • 10.3.6.2. U.S.: Dermal Fillers Market, by Product, 2020-2034 (USD Billion)
      • 10.3.6.3. U.S.: Dermal Fillers Market, by Drug Type, 2020-2034 (USD Billion)
      • 10.3.6.4. U.S.: Dermal Fillers Market, by Application, 2020-2034 (USD Billion)
      • 10.3.6.5. U.S.: Dermal Fillers Market, by End User, 2020-2034 (USD Billion)
    • 10.3.7. Dermal Fillers Market - Canada
      • 10.3.7.1. Canada: Dermal Fillers Market, by Material, 2020-2034 (USD Billion)
      • 10.3.7.2. Canada: Dermal Fillers Market, by Product, 2020-2034 (USD Billion)
      • 10.3.7.3. Canada: Dermal Fillers Market, by Drug Type, 2020-2034 (USD Billion)
      • 10.3.7.4. Canada: Dermal Fillers Market, by Application, 2020-2034 (USD Billion)
      • 10.3.7.5. Canada: Dermal Fillers Market, by End User, 2020-2034 (USD Billion)
  • 10.4. Dermal Fillers Market - Europe
    • 10.4.1. Europe: Dermal Fillers Market, by Material, 2020-2034 (USD Billion)
    • 10.4.2. Europe: Dermal Fillers Market, by Product, 2020-2034 (USD Billion)
    • 10.4.3. Europe: Dermal Fillers Market, by Drug Type, 2020-2034 (USD Billion)
    • 10.4.4. Europe: Dermal Fillers Market, by Application, 2020-2034 (USD Billion)
    • 10.4.5. Europe: Dermal Fillers Market, by End User, 2020-2034 (USD Billion)
    • 10.4.6. Dermal Fillers Market - UK
      • 10.4.6.1. UK: Dermal Fillers Market, by Material, 2020-2034 (USD Billion)
      • 10.4.6.2. UK: Dermal Fillers Market, by Product, 2020-2034 (USD Billion)
      • 10.4.6.3. UK: Dermal Fillers Market, by Drug Type, 2020-2034 (USD Billion)
      • 10.4.6.4. UK: Dermal Fillers Market, by Application, 2020-2034 (USD Billion)
      • 10.4.6.5. UK: Dermal Fillers Market, by End User, 2020-2034 (USD Billion)
    • 10.4.7. Dermal Fillers Market - France
      • 10.4.7.1. France: Dermal Fillers Market, by Material, 2020-2034 (USD Billion)
      • 10.4.7.2. France: Dermal Fillers Market, by Product, 2020-2034 (USD Billion)
      • 10.4.7.3. France: Dermal Fillers Market, by Drug Type, 2020-2034 (USD Billion)
      • 10.4.7.4. France: Dermal Fillers Market, by Application, 2020-2034 (USD Billion)
      • 10.4.7.5. France: Dermal Fillers Market, by End User, 2020-2034 (USD Billion)
    • 10.4.8. Dermal Fillers Market - Germany
      • 10.4.8.1. Germany: Dermal Fillers Market, by Material, 2020-2034 (USD Billion)
      • 10.4.8.2. Germany: Dermal Fillers Market, by Product, 2020-2034 (USD Billion)
      • 10.4.8.3. Germany: Dermal Fillers Market, by Drug Type, 2020-2034 (USD Billion)
      • 10.4.8.4. Germany: Dermal Fillers Market, by Application, 2020-2034 (USD Billion)
      • 10.4.8.5. Germany: Dermal Fillers Market, by End User, 2020-2034 (USD Billion)
    • 10.4.9. Dermal Fillers Market - Italy
      • 10.4.9.1. Italy: Dermal Fillers Market, by Material, 2020-2034 (USD Billion)
      • 10.4.9.2. Italy: Dermal Fillers Market, by Product, 2020-2034 (USD Billion)
      • 10.4.9.3. Italy: Dermal Fillers Market, by Drug Type, 2020-2034 (USD Billion)
      • 10.4.9.4. Italy: Dermal Fillers Market, by Application, 2020-2034 (USD Billion)
      • 10.4.9.5. Italy: Dermal Fillers Market, by End User, 2020-2034 (USD Billion)
    • 10.4.10. Dermal Fillers Market - Spain
      • 10.4.10.1. Spain: Dermal Fillers Market, by Material, 2020-2034 (USD Billion)
      • 10.4.10.2. Spain: Dermal Fillers Market, by Product, 2020-2034 (USD Billion)
      • 10.4.10.3. Spain: Dermal Fillers Market, by Drug Type, 2020-2034 (USD Billion)
      • 10.4.10.4. Spain: Dermal Fillers Market, by Application, 2020-2034 (USD Billion)
      • 10.4.10.5. Spain: Dermal Fillers Market, by End User, 2020-2034 (USD Billion)
    • 10.4.11. Dermal Fillers Market - Netherlands
      • 10.4.11.1. Netherlands: Dermal Fillers Market, by Material, 2020-2034 (USD Billion)
      • 10.4.11.2. Netherlands: Dermal Fillers Market, by Product, 2020-2034 (USD Billion)
      • 10.4.11.3. Netherlands: Dermal Fillers Market, by Drug Type, 2020-2034 (USD Billion)
      • 10.4.11.4. Netherlands: Dermal Fillers Market, by Application, 2020-2034 (USD Billion)
      • 10.4.11.5. Netherlands: Dermal Fillers Market, by End User, 2020-2034 (USD Billion)
    • 10.4.12. Dermal Fillers Market - Russia
      • 10.4.12.1. Russia: Dermal Fillers Market, by Material, 2020-2034 (USD Billion)
      • 10.4.12.2. Russia: Dermal Fillers Market, by Product, 2020-2034 (USD Billion)
      • 10.4.12.3. Russia: Dermal Fillers Market, by Drug Type, 2020-2034 (USD Billion)
      • 10.4.12.4. Russia: Dermal Fillers Market, by Application, 2020-2034 (USD Billion)
      • 10.4.12.5. Russia: Dermal Fillers Market, by End User, 2020-2034 (USD Billion)
    • 10.4.13. Dermal Fillers Market - Rest of Europe
      • 10.4.13.1. Rest of Europe: Dermal Fillers Market, by Material, 2020-2034 (USD Billion)
      • 10.4.13.2. Rest of Europe: Dermal Fillers Market, by Product, 2020-2034 (USD Billion)
      • 10.4.13.3. Rest of Europe: Dermal Fillers Market, by Drug Type, 2020-2034 (USD Billion)
      • 10.4.13.4. Rest of Europe: Dermal Fillers Market, by Application, 2020-2034 (USD Billion)
      • 10.4.13.5. Rest of Europe: Dermal Fillers Market, by End User, 2020-2034 (USD Billion)
  • 10.5. Dermal Fillers Market - Asia Pacific
    • 10.5.1. Asia Pacific: Dermal Fillers Market, by Material, 2020-2034 (USD Billion)
    • 10.5.2. Asia Pacific: Dermal Fillers Market, by Product, 2020-2034 (USD Billion)
    • 10.5.3. Asia Pacific: Dermal Fillers Market, by Drug Type, 2020-2034 (USD Billion)
    • 10.5.4. Asia Pacific: Dermal Fillers Market, by Application, 2020-2034 (USD Billion)
    • 10.5.5. Asia Pacific: Dermal Fillers Market, by End User, 2020-2034 (USD Billion)
    • 10.5.6. Dermal Fillers Market - China
      • 10.5.6.1. China: Dermal Fillers Market, by Material, 2020-2034 (USD Billion)
      • 10.5.6.2. China: Dermal Fillers Market, by Product, 2020-2034 (USD Billion)
      • 10.5.6.3. China: Dermal Fillers Market, by Drug Type, 2020-2034 (USD Billion)
      • 10.5.6.4. China: Dermal Fillers Market, by Application, 2020-2034 (USD Billion)
      • 10.5.6.5. China: Dermal Fillers Market, by End User, 2020-2034 (USD Billion)
    • 10.5.7. Dermal Fillers Market - India
      • 10.5.7.1. India: Dermal Fillers Market, by Material, 2020-2034 (USD Billion)
      • 10.5.7.2. India: Dermal Fillers Market, by Product, 2020-2034 (USD Billion)
      • 10.5.7.3. India: Dermal Fillers Market, by Drug Type, 2020-2034 (USD Billion)
      • 10.5.7.4. India: Dermal Fillers Market, by Application, 2020-2034 (USD Billion)
      • 10.5.7.5. India: Dermal Fillers Market, by End User, 2020-2034 (USD Billion)
    • 10.5.8. Dermal Fillers Market - Malaysia
      • 10.5.8.1. Malaysia: Dermal Fillers Market, by Material, 2020-2034 (USD Billion)
      • 10.5.8.2. Malaysia: Dermal Fillers Market, by Product, 2020-2034 (USD Billion)
      • 10.5.8.3. Malaysia: Dermal Fillers Market, by Drug Type, 2020-2034 (USD Billion)
      • 10.5.8.4. Malaysia: Dermal Fillers Market, by Application, 2020-2034 (USD Billion)
      • 10.5.8.5. Malaysia: Dermal Fillers Market, by End User, 2020-2034 (USD Billion)
    • 10.5.9. Dermal Fillers Market - Japan
      • 10.5.9.1. Japan: Dermal Fillers Market, by Material, 2020-2034 (USD Billion)
      • 10.5.9.2. Japan: Dermal Fillers Market, by Product, 2020-2034 (USD Billion)
      • 10.5.9.3. Japan: Dermal Fillers Market, by Drug Type, 2020-2034 (USD Billion)
      • 10.5.9.4. Japan: Dermal Fillers Market, by Application, 2020-2034 (USD Billion)
      • 10.5.9.5. Japan: Dermal Fillers Market, by End User, 2020-2034 (USD Billion)
    • 10.5.10. Dermal Fillers Market - Indonesia
      • 10.5.10.1. Indonesia: Dermal Fillers Market, by Material, 2020-2034 (USD Billion)
      • 10.5.10.2. Indonesia: Dermal Fillers Market, by Product, 2020-2034 (USD Billion)
      • 10.5.10.3. Indonesia: Dermal Fillers Market, by Drug Type, 2020-2034 (USD Billion)
      • 10.5.10.4. Indonesia: Dermal Fillers Market, by Application, 2020-2034 (USD Billion)
      • 10.5.10.5. Indonesia: Dermal Fillers Market, by End User, 2020-2034 (USD Billion)
    • 10.5.11. Dermal Fillers Market - South Korea
      • 10.5.11.1. South Korea: Dermal Fillers Market, by Material, 2020-2034 (USD Billion)
      • 10.5.11.2. South Korea: Dermal Fillers Market, by Product, 2020-2034 (USD Billion)
      • 10.5.11.3. South Korea: Dermal Fillers Market, by Drug Type, 2020-2034 (USD Billion)
      • 10.5.11.4. South Korea: Dermal Fillers Market, by Application, 2020-2034 (USD Billion)
      • 10.5.11.5. South Korea: Dermal Fillers Market, by End User, 2020-2034 (USD Billion)
    • 10.5.12. Dermal Fillers Market - Australia
      • 10.5.12.1. Australia: Dermal Fillers Market, by Material, 2020-2034 (USD Billion)
      • 10.5.12.2. Australia: Dermal Fillers Market, by Product, 2020-2034 (USD Billion)
      • 10.5.12.3. Australia: Dermal Fillers Market, by Drug Type, 2020-2034 (USD Billion)
      • 10.5.12.4. Australia: Dermal Fillers Market, by Application, 2020-2034 (USD Billion)
      • 10.5.12.5. Australia: Dermal Fillers Market, by End User, 2020-2034 (USD Billion)
    • 10.5.13. Dermal Fillers Market - Rest of Asia Pacific
      • 10.5.13.1. Rest of Asia Pacific: Dermal Fillers Market, by Material, 2020-2034 (USD Billion)
      • 10.5.13.2. Rest of Asia Pacific: Dermal Fillers Market, by Product, 2020-2034 (USD Billion)
      • 10.5.13.3. Rest of Asia Pacific: Dermal Fillers Market, by Drug Type, 2020-2034 (USD Billion)
      • 10.5.13.4. Rest of Asia Pacific: Dermal Fillers Market, by Application, 2020-2034 (USD Billion)
      • 10.5.13.5. Rest of Asia Pacific: Dermal Fillers Market, by End User, 2020-2034 (USD Billion)
  • 10.6. Dermal Fillers Market - Middle East & Africa
    • 10.6.1. Middle East & Africa: Dermal Fillers Market, by Material, 2020-2034 (USD Billion)
    • 10.6.2. Middle East & Africa: Dermal Fillers Market, by Product, 2020-2034 (USD Billion)
    • 10.6.3. Middle East & Africa: Dermal Fillers Market, by Drug Type, 2020-2034 (USD Billion)
    • 10.6.4. Middle East & Africa: Dermal Fillers Market, by Application, 2020-2034 (USD Billion)
    • 10.6.5. Middle East & Africa: Dermal Fillers Market, by End User, 2020-2034 (USD Billion)
    • 10.6.6. Dermal Fillers Market - Saudi Arabia
      • 10.6.6.1. Saudi Arabia: Dermal Fillers Market, by Material, 2020-2034 (USD Billion)
      • 10.6.6.2. Saudi Arabia: Dermal Fillers Market, by Product, 2020-2034 (USD Billion)
      • 10.6.6.3. Saudi Arabia: Dermal Fillers Market, by Drug Type, 2020-2034 (USD Billion)
      • 10.6.6.4. Saudi Arabia: Dermal Fillers Market, by Application, 2020-2034 (USD Billion)
      • 10.6.6.5. Saudi Arabia: Dermal Fillers Market, by End User, 2020-2034 (USD Billion)
    • 10.6.7. Dermal Fillers Market - UAE
      • 10.6.7.1. UAE: Dermal Fillers Market, by Material, 2020-2034 (USD Billion)
      • 10.6.7.2. UAE: Dermal Fillers Market, by Product, 2020-2034 (USD Billion)
      • 10.6.7.3. UAE: Dermal Fillers Market, by Drug Type, 2020-2034 (USD Billion)
      • 10.6.7.4. UAE: Dermal Fillers Market, by Application, 2020-2034 (USD Billion)
      • 10.6.7.5. UAE: Dermal Fillers Market, by End User, 2020-2034 (USD Billion)
    • 10.6.8. Dermal Fillers Market - Israel
      • 10.6.8.1. Israel: Dermal Fillers Market, by Material, 2020-2034 (USD Billion)
      • 10.6.8.2. Israel: Dermal Fillers Market, by Product, 2020-2034 (USD Billion)
      • 10.6.8.3. Israel: Dermal Fillers Market, by Drug Type, 2020-2034 (USD Billion)
      • 10.6.8.4. Israel: Dermal Fillers Market, by Application, 2020-2034 (USD Billion)
      • 10.6.8.5. Israel: Dermal Fillers Market, by End User, 2020-2034 (USD Billion)
    • 10.6.9. Dermal Fillers Market - South Africa
      • 10.6.9.1. South Africa: Dermal Fillers Market, by Material, 2020-2034 (USD Billion)
      • 10.6.9.2. South Africa: Dermal Fillers Market, by Product, 2020-2034 (USD Billion)
      • 10.6.9.3. South Africa: Dermal Fillers Market, by Drug Type, 2020-2034 (USD Billion)
      • 10.6.9.4. South Africa: Dermal Fillers Market, by Application, 2020-2034 (USD Billion)
      • 10.6.9.5. South Africa: Dermal Fillers Market, by End User, 2020-2034 (USD Billion)
    • 10.6.10. Dermal Fillers Market - Rest of Middle East & Africa
      • 10.6.10.1. Rest of Middle East & Africa: Dermal Fillers Market, by Material, 2020-2034 (USD Billion)
      • 10.6.10.2. Rest of Middle East & Africa: Dermal Fillers Market, by Product, 2020-2034 (USD Billion)
      • 10.6.10.3. Rest of Middle East & Africa: Dermal Fillers Market, by Drug Type, 2020-2034 (USD Billion)
      • 10.6.10.4. Rest of Middle East & Africa: Dermal Fillers Market, by Application, 2020-2034 (USD Billion)
      • 10.6.10.5. Rest of Middle East & Africa: Dermal Fillers Market, by End User, 2020-2034 (USD Billion)
  • 10.7. Dermal Fillers Market - Latin America
    • 10.7.1. Latin America: Dermal Fillers Market, by Material, 2020-2034 (USD Billion)
    • 10.7.2. Latin America: Dermal Fillers Market, by Product, 2020-2034 (USD Billion)
    • 10.7.3. Latin America: Dermal Fillers Market, by Drug Type, 2020-2034 (USD Billion)
    • 10.7.4. Latin America: Dermal Fillers Market, by Application, 2020-2034 (USD Billion)
    • 10.7.5. Latin America: Dermal Fillers Market, by End User, 2020-2034 (USD Billion)
    • 10.7.6. Dermal Fillers Market - Mexico
      • 10.7.6.1. Mexico: Dermal Fillers Market, by Material, 2020-2034 (USD Billion)
      • 10.7.6.2. Mexico: Dermal Fillers Market, by Product, 2020-2034 (USD Billion)
      • 10.7.6.3. Mexico: Dermal Fillers Market, by Drug Type, 2020-2034 (USD Billion)
      • 10.7.6.4. Mexico: Dermal Fillers Market, by Application, 2020-2034 (USD Billion)
      • 10.7.6.5. Mexico: Dermal Fillers Market, by End User, 2020-2034 (USD Billion)
    • 10.7.7. Dermal Fillers Market - Brazil
      • 10.7.7.1. Brazil: Dermal Fillers Market, by Material, 2020-2034 (USD Billion)
      • 10.7.7.2. Brazil: Dermal Fillers Market, by Product, 2020-2034 (USD Billion)
      • 10.7.7.3. Brazil: Dermal Fillers Market, by Drug Type, 2020-2034 (USD Billion)
      • 10.7.7.4. Brazil: Dermal Fillers Market, by Application, 2020-2034 (USD Billion)
      • 10.7.7.5. Brazil: Dermal Fillers Market, by End User, 2020-2034 (USD Billion)
    • 10.7.8. Dermal Fillers Market - Argentina
      • 10.7.8.1. Argentina: Dermal Fillers Market, by Material, 2020-2034 (USD Billion)
      • 10.7.8.2. Argentina: Dermal Fillers Market, by Product, 2020-2034 (USD Billion)
      • 10.7.8.3. Argentina: Dermal Fillers Market, by Drug Type, 2020-2034 (USD Billion)
      • 10.7.8.4. Argentina: Dermal Fillers Market, by Application, 2020-2034 (USD Billion)
      • 10.7.8.5. Argentina: Dermal Fillers Market, by End User, 2020-2034 (USD Billion)
    • 10.7.9. Dermal Fillers Market - Rest of Latin America
      • 10.7.9.1. Rest of Latin America: Dermal Fillers Market, by Material, 2020-2034 (USD Billion)
      • 10.7.9.2. Rest of Latin America: Dermal Fillers Market, by Product, 2020-2034 (USD Billion)
      • 10.7.9.3. Rest of Latin America: Dermal Fillers Market, by Drug Type, 2020-2034 (USD Billion)
      • 10.7.9.4. Rest of Latin America: Dermal Fillers Market, by Application, 2020-2034 (USD Billion)
      • 10.7.9.5. Rest of Latin America: Dermal Fillers Market, by End User, 2020-2034 (USD Billion)

11. Competitive Landscape

  • 11.1. Expansion and Acquisition Analysis
    • 11.1.1. Expansion
    • 11.1.2. Acquisitions
  • 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

  • 12.1. AbbVie Inc.
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Recent Development
  • 12.2. BIOPLUS CO., LTD.
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Recent Development
  • 12.3. Bioxis Pharmaceuticals
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Recent Development
  • 12.4. Bioha Laboratories
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Recent Development
  • 12.5. Cutera, Inc.
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Recent Development
  • 12.6. Elan Aesthetics, Inc.
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Benchmarking
    • 12.6.4. Recent Development
  • 12.7. Galderma S.A.
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Benchmarking
    • 12.7.4. Recent Development
  • 12.8. HUADONG MEDICINE CO., LTD.
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Benchmarking
    • 12.8.4. Recent Development
  • 12.9. Merz Pharma GmbH & Co. KGaA
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Benchmarking
    • 12.9.4. Recent Development
  • 12.10. Prollenium Medical Technologies Inc.
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Benchmarking
    • 12.10.4. Recent Development
  • 12.11. Revance Therapeutics, Inc.
    • 12.11.1. Company Overview
    • 12.11.2. Financial Performance
    • 12.11.3. Product Benchmarking
    • 12.11.4. Recent Development
  • 12.12. Sinclair Pharma Limited
    • 12.12.1. Company Overview
    • 12.12.2. Financial Performance
    • 12.12.3. Product Benchmarking
    • 12.12.4. Recent Development
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦